[
    [
        {
            "time": "2023-08-15",
            "original_text": "Best Dividend Stocks to Buy in August",
            "features": {
                "keywords": [
                    "dividend",
                    "stocks",
                    "buy",
                    "august"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Best Dividend Stocks to Buy in August",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-08-15",
            "original_text": "JAMA Dermatology Publishes Data Showing RINVOQ速 (upadacitinib) Achieved Superiority Versus DUPIXENT速 (dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis",
            "features": {
                "keywords": [
                    "RINVOQ",
                    "upadacitinib",
                    "DUPIXENT",
                    "dupilumab",
                    "superiority",
                    "phase 3b",
                    "atopic dermatitis"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "JAMA Dermatology Publishes Data Showing RINVOQ速 (upadacitinib) Achieved Superiority Versus DUPIXENT速 (dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-08-15",
            "original_text": "10 Best Dividend Paying Stocks to Buy Now",
            "features": {
                "keywords": [
                    "dividend",
                    "paying",
                    "stocks",
                    "buy",
                    "now"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "10 Best Dividend Paying Stocks to Buy Now",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-08-15",
            "original_text": "Dividend Aristocrats AbbVie, Exxon Mobil and IBM Are Three Good Buys",
            "features": {
                "keywords": [
                    "dividend aristocrats",
                    "abbvie",
                    "exxon mobil",
                    "ibm",
                    "good buys"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "healthcare",
                    "energy",
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dividend Aristocrats AbbVie, Exxon Mobil and IBM Are Three Good Buys",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]